~~<i id='BB5F02117D'><strike id='BB5F02117D'><tt id='BB5F02117D'><pre id='BB5F02117D'></pre></tt></strike></i>~~

Home» explore» knowledge

knowledge

author：leisure time 2025-09-27 11:20:35 Page View：24

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bird flu surveillance in wastewater gets boost from consortium
Next article： How one medical school became remarkably diverse

Wikipedia

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

1:30PoliceofficerscoordinatethesearchforawildanimalinaresidentialareainTeltow,Germany,ThursdayJuly20

After affirmative action ruling, medical educators look to 'holistic review'

AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

Indian pharmaceutical industry in denial over drug

AchemistworksatapharmaceuticalmanufacturingplantontheoutskirtsofMumbai.Drugmakersinthecountryhavecom

WSS

knowledge

knowledge

focus

Wikipedia

Indian pharmaceutical industry in denial over drug